SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006554
Filing Date
2024-11-14
Accepted
2024-11-14 12:00:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 APPLIED THERAPEUTICS, INC. p24-3221sc13ga.htm SC 13G/A 61047
  Complete submission text file 0000902664-24-006554.txt   62710
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Subject) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91017 | Film No.: 241459103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 632 BROADWAY SUITE 602 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 602 NEW YORK NY 10012 6469894000
Vestal Point Capital, LP (Filed by) CIK: 0001974915 (see all company filings)

IRS No.: 922296021 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A